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Abstract
Background: Fluid overload (FO) is associated with unfavorable outcomes in critically ill children. Clinicians are
encouraged to avoid FO; however, strategies to avoid FO are not well-described in pediatrics. Our aim was to
implement a bundle strategy to prevent FO in children with sepsis and pARDS and to compare the outcomes with
a historical cohort.
Methods: A quality improvement initiative, known as preemptive fluid strategy (PFS) was implemented to prevent
early FO, in a 12-bed general PICU. Infants on mechanical ventilation (MV) fulfilling pARDS and sepsis criteria were
prospectively recruited. For comparison, data from a historical cohort from 2015, with the same inclusion and exclusion
criteria, was retrospectively reviewed. The PFS bundle consisted of 1. maintenance of intravenous fluids (MIVF) at 50%
of requirements; 2. drug volume reduction; 3. dynamic monitoring of preload markers to determine the need for fluid
bolus administration; 4. early use of diuretics; and 5. early initiation of enteral feeds. The historical cohort treatment, the
standard fluid strategy (SFS), were based on physician preferences. Peak fluid overload (PFO) was the primary outcome.
PFO was defined as the highest FO during the first 72 h. FO was calculated as (cumulative fluid input – cumulative
output)/kg*100. Fluid input/output were registered every 12 h for 72 h.
Results: Thirty-seven patients were included in the PFS group (54% male, 6 mo (IQR 2,11)) and 39 with SFS (64%male,
3 mo (IQR1,7)). PFO was lower in PFS (6.31% [IQR4.4–10]) compared to SFS (12% [IQR8.4–15.8]). FO was lower in PFS
compared to CFS as early as 12 h after admission [2.4(1.4,3.7) v/s 4.3(1.5,5.5), p < 0.01] and maintained during the study.
These differences were due to less fluid input (MIVF and fluid boluses). There were no differences in the renal function
test. PRBC requirements were lower during the first 24 h in the PFS (5%) compared to SFS (28%, p < 0.05). MV duration
was 81 h (58,98) in PFS and 118 h (85154) in SFS(p < 0.05). PICU LOS in PFS was 5 (4, 7) and in SFS was 8 (6, 10) days.
Conclusion: Implementation of a bundle to prevent FO in children on MV with pARDS and sepsis resulted in less PFO.
We observed a decrease in MV duration and PICU LOS. Future studies are needed to address if PFS might have a
positive impact on health outcomes.
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Background
During the last two decades, intravenous fluid administra-
tion has been the cornerstone of treatment of children
with hemodynamic instability. Restoration of circulating
blood volume and perfusion to tissues is the primary end
point of this therapy, decreasing mortality and morbidity
of critically ill children with clinical signs of poor perfu-
sion and shock [1]. Supported by guidelines and protocols,
rapid administration of intravenous fluid is currently one
of the most frequent interventions in critical care [2–5].
Intravenous (IV) fluid resuscitation may be lifesaving, but
many studies have found that positive fluid balance is as-
sociated with negative outcomes in many clinical scenar-
ios [6–15]. Critically ill patients are especially prone to
positive fluid balance due to excessive fluid input (resusci-
tation fluids, maintenance intravenous fluid, continuous
drug infusions, blood products and IV treatments), limited
elimination of fluids (due to counterregulatory mecha-
nisms such as antidiuretic hormone secretion) and due to
capillary leakage in the interstitium, resulting in organ
edema and dysfunction [16–19]. Detrimental effects are
very pronounced in organs with a high density of capillar-
ies, such as the lung, due to capillary leakage associated
with a high hydrostatic pressure [16, 19–21]. Fluid over-
load has been associated with pulmonary dysfunction,
hypoxia, longer duration of mechanical ventilation and
ICU stay in children and adults on mechanical ventilation
(MV) [6, 7, 13, 15, 20, 22–24]. In contrast, in the setting
of acute respiratory distress syndrome (ARDS), diuretic
use and restrictive fluid management are associated with
lower mortality and faster liberation from MV, respectively
[18, 24–26].
Despite these overwhelming data, few studies in
pediatrics have addressed how to avoid significant fluid
overload in patients under MV.
The objective of this study was to describe the imple-
mentation of a preemptive fluid strategy in children with
sepsis and ARDS. In addition, a comparison with an his-
torical cohort of infants was made.
Methods
Expedited review by the IRB approved the quality im-
provement project, waiving the requirement for a writ-
ten consent.
Setting: During a 12-month period (January to December
2016), all children admitted to the Pediatric Intensive Care
Unit at Hospital Padre Hurtado were screened. Our unit is
a 12-bed general medical and surgical PICU and does not
take care of patients after congenital heart surgery or those
receiving a transplant.
Participants: All patients younger than 24-months who
received MV and fulfilled the pediatric ARDS (pARDS)
and sepsis criteria, were prospectively identified. pARDS
was defined according to the PALICC criteria [27] and
sepsis was defined according to the International Pediatric
Sepsis Consensus Conference definitions [28]. Patients
were excluded if they were younger than 28 days old, had
chronic renal insufficiency or end-stage renal disease, re-
quired dialysis, had a cyanotic congenital heart disease,
underwent tracheostomy or required the chronic use of a
positive pressure ventilation system.
Preemptive fluid strategy (PFS)
As previously reported [29], this protocol was developed
following 5 principles, in the post-resuscitation phase of
critical illness:
1. Maintenance of intravenous fluids (MIVF) at 50% of
baseline requirements estimated by the Holliday-
Segar formula, ensuring adequate glucose infusion
rate for normoglycemia.
2. Preparation of continuous infusions of medications
(sedation and vasoactive drugs) and intravenous
treatments (e.g., antibiotics) concentrated to the
minimum volume recommended. Use of miniaturized
devices for hemodynamic monitoring (i.e., pressure
transducers) at the minimum rate of saline infusion.
3. Use of dynamic preload markers (pulse pressure
variation) in addition to clinical assessment to
decide administration of fluid boluses and early
titration of vasoactive drugs.
4. Consideration of early use of diuretics when
hypovolemia was ruled out, resuscitation goals were
met and urinary output was less than 0.5 ml/kg/h.
5. Early initiation of enteral feeds.
A Historical cohort data was collected retrospectively
with the same inclusion/exclusion criteria from June
2014 to December 2015. These patients were treated
with standard fluid strategy and compared with the pro-
spectively collected data of the patients managed with
PFS.
Standard fluid strategy (SFS)
Standard fluid strategy can be summarized as:
1. Resuscitation phase: hemodynamic resuscitation
based on Surviving Sepsis Campaign [2, 3].
2. Stabilization phase: patients received MIVF at 100%
of baseline requirements estimated by the Holliday-
Segar formula.
3. Depletive phase: Initiation of diuretics after meeting
resuscitation end points, hemodynamic stability and
absence of any marker of dysoxia.
Data collection
Demographic and clinical data were recorded in a relational
database. Fluid intake and output (I/O) were recorded every
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12 h during the first 3 days after admission. To determine
the causes of fluid overload and variations in clinical prac-
tice after initiation of the protocol, fluid intake was divided
into MIVF, fluid bolus, enteral feeds, drug administration
(e.g., antibiotics) and packed red blood cells (PRBC) trans-
fusions. Renal function was monitored daily and electrolyte
alterations were monitored every 12 h or more frequently
depending on the treating physician’s assessment. Urinary
output and diuretic use were also recorded.
Vasoactive drug (VAD) support was recorded and max-
imum vasoactive inotropic score (VIS) score was calcu-
lated daily [30]. The percent of fluid overload (FO) was
calculated using the following formula: [(total fluid intake
(L) − total fluid output in liters (L)) / (admission weight in
kilograms)*100] [31]. Peak FO was defined as the max-
imum percentage of FO during the first 72 h after initi-
ation of invasive MV. No data were collected before PICU
admission.
The primary outcome was to measure peak fluid over-
load (PFO). Fluid input and output were recorded as sec-
ondary outcomes to determine the causes of FO. Other
clinical outcomes such as duration of MV, hospital and
PICU length of stay (LOS) were recorded.
Statistical considerations
Descriptive statistics were used to summarize all continu-
ous and categorical variables. Comparisons between patient
groups were performed using Fisher’s exact test for categor-
ical variables and the Mann-Whitney U test for continuous
variables because of concerns about the normality of the
distribution of these variables. Two-way repeated measures
ANOVA test was performed for comparisons (fluid over-
load) among and between groups during the study period.
All statistical tests were 2-sided and were performed with a
P-value less than 0.05 indicating statistical significance. The
SPSS software package (version 20.0; SPSS, Chicago, IL,
USA) was used for the statistical analyses.
Results
Thirty-seven patients were included in the PFS group and
compared with 39 patients in the SFS group (Table 1). No
mortality was noted in this cohort.
Fluid overload was significantly lower in the PFS group
compared to the SFS group at 12, 24, 36, 48, 60 and
72 h (P < 0.05) (Fig. 1). PFO was significantly lower in
the PFS group (6.31% [IQR 4.4–10]) compared to the
SFS group (12% [IQR 8.4–15.8]).
The PFS group required significantly less fluid input due
to less MIVF and fewer resuscitation boluses compared to
SFS (Fig. 2a and b). The PFS group had a lower urinary
output, but renal function tests were not different from
the SFS group. Diuretic use was frequent in both groups,
at 24 h 54% of patients on PFS received at least one diur-
etic bolus and 15% of patients on SFS (P = 0.003). The SFS
group required more frequent continuous infusions of di-
uretics at 48 and 72 h. (Table 2).
Table 1 Demographics and clinical outcomes of septic
children with ARDS on preemptive fluid strategy and standard
fluid strategy
Preemptive Conservative
N 37 39
Male 54% 64%
Age (mo) 6 (2,11)* 3 (1,7)
Weight (kg) 8.4 (5.4,10)* 5 (4.7,9)
Comorbility 38% 49%
RSV 54% 51%
P/F ratio at admission 207 (146,249) 193 (146,234)
Duration of MV (h) 81 (58,98)* 118 (85.5154.5)
PICU LOS (days) 5 (4,7)* 8 (6,10)
(*P < 0.05)
Abbreviations: ARDS acute respiratory distress syndrome, RSV respiratory
syncytial virus; P/F ratio PaO2/FiO2 ratio, MV mechanical ventilation, PICU LOS
pediatric intensive care unit length of stay
Fig. 1 Box plot graph of cumulative and peak fluid overload during the first 72 h after admission in children with sepsis and ARDS with preemptive
fluid strategy (white) and standard fluid strategy (gray). (* P < 0.05). Abbreviations: ARDS: acute respiratory distress syndrome; PFO: peak fluid overload
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PRBC transfusions were less frequent in the first 12 h
after admission in the PFS group. Enteral feeds were started
earlier in the PFS group (Table 3). The median duration of
vasoactive drug support was 2 days (0,3) in the PFS group
and 3 days [2, 4] in the SFS group (P = 0.018) and VIS was
significantly lower during the first and the third day of ad-
mission in the PFS group. Use of greater than or equal to 2
vasoactive drugs was more frequent in the SFS group dur-
ing the third day after admission (Table 3). Epinephrine
support was more frequent in the SFS group during the
first day after admission, whereas norepinephrine was more
frequent during the third day after admission in the same
group (Additional file 1: Figure S1).
Time to successful extubation was 81.5 h [IQR 56.5–
100.5] in the PFS group and 118 h [IQR 85.5–154.5] in
the SFS group (P < 0.01 by the log rank test). Addition-
ally, PICU LOS was shorter in the PFS group compared
to the SFS group (5 days [IQR 4–7] vs 8 days [IQR 6–10],
P < 0.01).
Discussion
The main finding of our study is that prevention of fluid
overload as a bundle for critically ill children was success-
fully implemented in a general PICU. Critically ill children
with sepsis and pARDS that underwent preemptive fluid
strategy had less peak fluid overload compared with stand-
ard fluid strategy. These differences were due to a lower
requirement for fluid input from MIVF and fluid bolus re-
suscitation, especially during the first 48 h. No detrimental
effects were found on renal function test, urinary output
or vasoactive drugs requirements.
The detrimental effects of fluid overload in critically ill
children have been extensively reported in many different
settings [6–15, 20–23], but this study is the first one to
offer an alternative approach to avoid early fluid overload.
We developed this bundle based on preliminary data (29)
that showed that excessive fluid administration during the
first 72 h after admission was the main responsible factor
for early fluid overload during the course of critical illness.
Fig. 2 Maintenance intravenous fluid administration (ml·kg−1·12 h−1)
in both groups during the study intervals after admission (a). Percentage
of patients that received at least one fluid bolus during the study
intervals after admission (b). (* P < 0.05). Abbreviations: PFS: preemptive
fluid strategy; SFS: standard fluid strategy
Table 2 Renal function test, urinary output and percentage of patients that received diuretics in the preemptive fluid strategy and
standard fluid strategy groups
24 h 48 h 72 h
PFS SFS PFS SFS PFS SFS
N 37 39 36 39 24 37
BUN (mg·dL−1) 7 (6,9.5) 4 (3,8) 5 (3,8) 3 (2,6) 7 (5,16) 4 (2,8.5)
Creatinine (mg·dL−1) 0.22 (0.16,0.28) 0.18 (0.14,0.24) 0.21 (0.19,0.3) 0.2 (0.15,0.26) 0.22 (0.14,0.35) 0.22 (0.19,0.36)
Urinary output (mL·kg−1·h−1) 1.8* (1.1,2.8) 2.9 (1.8,3.7) 2.3* (1.6,3.5) 4 (2.9,5.7) 2.6* (2.1,3.75) 4.1 (3,5.2)
Diuretic bolus (%) 54* 15 72 64 57 76
Continuous infusion of diuretic (%) 11 13 19* 59 17* 70
(* P < 0.05)
Abbreviations: PFS preemptive fluid strategy, SFS standard fluid strategy
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Maintenance intravenous fluid calculation in current
practices is based on the Holliday-Segar method, which
was developed many decades ago. It is important to note
that this method was supposed to estimate the 24 h
water loss in hospitalized euvolemic children with nor-
mal renal function [32]. This method was not developed
for use in critically ill infants, so it does not account for
all the peculiarities of this group of patients. For ex-
ample, febrile illness and tachypnea can increase insens-
ible water loss. On the other hand, energy expenditure is
lower in infants sedated and on MV and insensible water
losses are very low in normothermic infants breathing
humidified gas [32, 33]. Based on these data, we de-
creased MIVF to 50% of the calculated rate while main-
taining the glucose infusion rates for infants to avoid
hypoglycemia.
The second element of the bundle was fluid bolus ad-
ministration. In addition to the clinical assessment of
hypovolemia, we added to our bundle a dynamic preload
parameter, pulse pressure variation, to decide on fluid
administration. Resuscitation protocols and guidelines
propose an aggressive fluid management approach as
the first line treatment for sepsis and shock [1, 2]. The
main objective of fluid bolus administration is to correct
hypovolemia, a common initial finding in pediatric sepsis
and shock [34]. Currently, fluid bolus administration is a
frequent intervention in the emergency department and
most of the patients receive between 20 and 60 mL·kg− 1
before PICU admission [35]. The risks and unwanted ef-
fects of this approach have been highlighted in recent
studies [36–38]. Adequate fluid resuscitation increases
venous return, end diastolic and systolic volume and
consequently stroke volume and cardiac index. Despite
the widespread clinical use, data supporting fluid bolus
therapy in hospitalized critically ill children is very weak
[39]. Recent adult studies have emphasized that liberal
use of fluid bolus is associated with a positive fluid bal-
ance, exposing patients to the risks associated with fluid
overload [24–26]. We acknowledge that the functional
hemodynamic markers of preload are not widely used in
critically ill children. Most devices providing invasive
arterial pressure monitoring can give at least pulse pres-
sure variation parameters with the current technology.
In our view, functional hemodynamic monitoring gives
to the clinician an additional parameter to assess fluid
status and predict fluid responsiveness, along with vital
signs, physical examinations and biomarkers of dysoxia.
Only 50% of critical ill children are fluid responders
[40], due to myocardial dysfunction and blunted adren-
ergic sensitivity [40, 41]. Additionally, it is important to
recall that fluid hemodynamic response is short. It is es-
timated that 85% of crystalloid fluid boluses redistribute
in the interstitial tissue four hours after administration
or even less in critically ill patients having an increased
capillary leak [5, 42]. In daily practice fluid boluses are
the first response to multiple scenarios without a strong
physiological support, i.e., tachycardia due to fever, re-
spiratory distress or pain. With PFS, we were able to de-
crease fluid boluses, especially during the first 24 h,
without any clinical evidence of detrimental hypovolemia
or significant renal dysfunction. Urinary output was
lower in PFS, and diuretic initiation was more frequent
during the first 24 h after admission, but renal function
tests where similar between groups. Limiting unneces-
sary fluid administration in the PFS group was also as-
sociated with less PRBC transfusions, probably as a
result of a decreased hemodilution. Vasoactive drug
support was lower in the PFS group. This may seem
counterintuitive, but studies in adults have shown that
hemodynamic instability is associated with liberal use
of fluids [43–47].
The initiation of enteral feeds occurred earlier in the
PFS group. From the practical standpoint, enteral feeds
allow to decrease unnecessary MIVF, improve nutritional
support and are essential for the metabolic homeostasis
of critically ill patient. In addition, several non-nutritive
benefits of enteral feeds have been described, such as
anti-inflammatory and immunomodulatory effects, which
may have a major impact on the outcome of patients with
ARDS [48–50]. In our center, as in many PICUs, early ini-
tiation of enteral feeds has become a priority and a quality
standard.
Table 3 Percentage of patients of each group that received packed red blood cell transfusion, enteral feeds and 2 or more
vasoactive drugs at different study points
12 h 24 h 36 h 48 h 60 h 72 h
PFS SFS PFS SFS PFS SFS PFS SFS PFS SFS PFS SFS
(N) 37 39 37 39 37 39 36 39 33 38 24 37
PRBC 5%* 28% 27% 26% 14% 10% 6% 10% 3% 5% 0% 3%
Enteral Feeds 16%* 0% 59%* 28% 84%* 49% 92% 77% 84% 87% 83% 78%
VIS 3.43 7.76* 5.07 7.87 3.22* 6.37
≥2 VAD 11% 18% 16% 31% 3%* 21%
Highest calculated vasoactive inotropic score during the first, second and third day. (*P < 0.05)
Abbreviations: PFS preemptive fluid strategy, SFS standard fluid strategy, PRBC packed red blood cell transfusion, VAD vasoactive drugs, VIS vasoactive inotropic score
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We found that PFS was associated with less MV days and
PICU LOS, with similar findings being reported from stud-
ies in adults. Although this study was not designed to ad-
dress these outcomes, we believe that these observations set
the target and basis for future prospective studies in the
field. A recent systematic review and meta-analysis reported
that in adults and children with ARDS and sepsis, a conser-
vative fluid strategy resulted in an increased number of
ventilator-free days and a decreased length of ICU stay com-
pared with a more liberal strategy or standard care [26].
Our study has some limitations. No data were gathered
before PICU admission. The described strategy, PFS, does
not apply for patients during resuscitation from septic
shock. Adequate initial fluid resuscitation of patients in
septic shock decreases mortality and has been well docu-
mented in many studies [1–4, 34], but the goals and met-
rics of these interventions need to be redefined. No
specific data of the endpoints of resuscitation were regis-
tered, so it is difficult to extrapolate our protocol to un-
stable patients with ongoing signs of poor perfusion or
dysoxia. Specifically, it is controversial what objective data
the clinician must consider to terminate the resuscitation
phase. All the patients included in this study suffered from
sepsis due to acute pulmonary infectious diseases. There-
fore, the findings in this study cannot be directly extrapo-
lated to patients with extrapulmonary pARDS. Our
measurements and outcomes were short-term and ob-
tained upon PICU admission, so we cannot extrapolate
the long-term effects using this approach. Finally, we must
acknowledge the limitations of comparing our findings
with a historical retrospective cohort, especially since se-
lection bias and type II error cannot be ruled out.
Conclusion
We successfully implemented a quality improvement
initiative to prevent early fluid overload in critically ill
children. In our view, clinicians must be aware that a
systematic approach with measures specifically limiting
unnecessary fluid input (MIVF and resuscitation fluid
bolus) over the first 48 h can be easily applied in most
PICU and may prevent significant FO.
Future collaborative studies are needed to address if a
preemptive fluid strategy after resuscitation from shock,
in addition to optimal care for pARDS (protective mechan-
ical ventilation, avoidance of patient ventilator asynchrony,
optimal nutrition, weaning protocol, among others) might
have a positive impact in outcomes.
Additional file
Additional file 1: Figure S1. Vasoactive drug use in standard fluid
strategy and preemptive fluid strategy at day 1, 2 and 3 of study. * P < 0.05.
Abbreviations: PFS: preemptive fluid strategy; SFS: standard fluid strategy.
(JPG 226 kb)
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